Accidental Early Diagnosis of Endometrial Adenocarcinoma by Pap Smear during a Cervical Cancer Prevention Study: A Case Report

Jayashree Joshi, Sham Ratnaparkhi , Priya Walwatker , Sujata Jagtap , Neerja Rastogi

Jayashree Joshi, Sham Ratnaparkhi , Priya Walwatker , Sujata Jagtap , Neerja Rastogi Joint Research Director, MRC- Kasturba Health Society, Mumbai & Former Deputy Director, NIRRH, ICMR

Keywords: Pap smears, Endometrial carcinoma, Cervical Cancer Prevention, Cancer screening, Risk factors for cancer, Early diagnosis of endometrial adenocarcinoma

Abstract

Endometrial carcinoma is less common than cervical cancer but the disadvantage is that there is no mass screening method that can be used for early detection or prevention. The Papanicolaou (Pap) smear is useful for screening and preventing cervical cancer but occasionally also detects endometrial cancer, usually in advanced stages. Here we describe a case of endometrial cancer which was not detected in the initial Pap smear of a 40 year old woman. She had Low-Grade Intraepithelial Squamous Lesion (LSIL) with normal endocervical cells in the initial smear. Since she participated in a cervical cancer prevention study with antimicrobials and turmeric extract, her Pap smear was repeated within 5 weeks. Endometrial adenocarcinoma was clearly suspected in this follow-up Pap smear and the case was subsequently investigated and confirmed as Endometrial carcinoma. This case is presented for its rarity of clinical features: younger age, absence of common risk factors, and early detection because of cervical cancer prevention programs. A review of the literature reveals the potential of curcumin and turmeric extracts in controlling gynaecological cancers.
Conflict of Interest: None of the authors have any conflict of interest related to the products or diagnostic methods mentioned in this communication.

References

1. Khazaei Z, Dehkordi AH, Amiri M et al. The incidence and mortality of endometrial cancer and its association with
body mass index and human development index in Asian population. WCRJ 2018; 5: e1174:1-11.
2. American Cancer Society: Cancer Prevention & Early Detection. Facts & Figures 2019-2020.
3. Nayar R, Wilbur DC. The Pap Test and Bethesda 2014. Acta Cytologica 2015;59: 121–132.
4. Gerbera B, Krausea H, Mullera H et al. Ultrasonographic detection of asymptomatic endometrial cancer in postmenopausal
patients offers no prognostic advantage over symptomatic disease discovered by uterine bleeding. Europ J
Cancer, 2001; 37: 64-71.
5. Joshi JV, Saraiya UB. The cytological diagnosis of adenocarcinoma of the female genital tract. Ind J Cancer 1975;12: 274-
278.
6. Asma N, Hephzibah R, Parinitha SS, Rao R, Shastri D. Pap Smear in Endometrial Adenocarcinoma: Does It Have a
Role? Asian Pac J Cancer Prev, 2017;18 : 1145-1150.
7. Joshi JV, Jagtap SS, Rastogi N et al. Integrated treatment with antimicrobials and oral turmeric extract Haldone® for
women with cervical Low Grade Squamous Intraepithelial Lesions. Innovative Technologies, Late Breaking Abstracts;
Abstract ID 000638- ASCCP2019 4-6 April, 2019, Atlanta, USA, Pg 11.
8. Shivprasad C. Sheehan’s syndrome: Newer advances. Indian J Endocrinol Metab. 2011; 15(Suppl3): S203–S207.
9. Joshi JV, Rastogi N, Jagtap SS et al. Accidental Early Diagnosis of Adenocarcinoma of Endometrium During
Close Monitoring in Haldone® Study (Case Report). Poster presentation, International Conference on Women’s Reproductive Health, Golden Jubilee Conference by NIRRH, ICMR, 20-23rd February, 2020.
10. Beral V, Bull D, Reeves G. Million Women Study Collaborators. Endometrial cancer and hormone-replacement
therapy in the Million Women Study. Lancet. 2005; 365: 1543-51.
11. Joshi JV, Paradkar PH , Jagtap SS, et al. Chemopreventive Potential & Safety Profile of NBFR-03 (Supercritical
Curcuma longa exract) in Women with Cervical Low- Grade Squammous Intraepithelial Neoplasia in Papanicolaou
Smears. Asian Pacific J Cancer Prev, 2011;12:3305-11.
12. Joshi JV, Paradkar PH, Jagtap S et al (2016). Persistent chemopreventive action of integrative treatment of Low-Grade
Cervical Intraepithelial Neoplasia- Case series. Journal of Ayurveda and Integrative Medicine 7:109-12.
13. Shanmugam M, Rane G, Mathi Kanchi MM et al. The multifaceted role of curcumin in cancer prevention and treatment.
Molecules 2015; 20: 2728-69.
14. Paradkar P, Dandekar S, Joshi JV, Amonkar AJ, Vaidya AB. Synergistic Anticancer Activity of the Medicinal Plant
Bioactives: Curcuma Longa Linn And Tinospora Cordifolia Willd. in Cervical Cancer. Int J Pharm Sci Rev Res. 2017;
42:151-60.
15. Chen Q, Gao Q, Chen K et al. Curcumin suppresses migration and invasion of human endometrial carcinoma cells.
Oncol Lett. 2015 ; 10: 1297–1302.
16. Saydmohammed M, Joseph D, Syed V. Curcumin suppresses constitutive activation of STAT-3 by up-regulating protein
inhibitor of activated STAT-3 (PIAS-3) in ovarian and endometrial cancer cells. J Cell Biochem. 2010;110:447-56.
17. Sirohi VK, Popli P, Sankhwar P et al. Curcumin exhibits antitumor effect and attenuates cellular migration via Slit-2 mediated
down-regulation of SDF-1 and CXCR4 in endometrial adenocarcinoma cells. J Nutr Biochem. 2017;44:60-70.
18. Khoury DE, Matar R, Touma T. Curcumin and endometrial carcinoma: an old spice as a novel agent. Int J Women’s
Health. 2019; 11: 249–256.
19. Tuyaerts S, Rombauts K, Everaert T et al. A Phase 2 Study to Assess the Immunomodulatory Capacity of a Lecithinbased
Delivery System of Curcumin in Endometrial Cancer. Front. Nutr. 2018; 5:1-14.